124 related articles for article (PubMed ID: 2979692)
1. The effect of calcium channel blockade with nifedipine on splanchnic and systemic haemodynamics in cirrhosis.
Macmathuna P; O'Reilly T; Kelleher D; Barry M; Feely J; Keeling PW
Aliment Pharmacol Ther; 1987 Dec; 1(6):639-42. PubMed ID: 2979692
[TBL] [Abstract][Full Text] [Related]
2. Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis.
Ota K; Shijo H; Kokawa H; Kubara K; Kim T; Akiyoshi N; Yokoyama M; Okumura M
J Gastroenterol Hepatol; 1995; 10(2):198-204. PubMed ID: 7787167
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
Braillon A; Calès P; Lebrec D
Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of nifedipine on hepatic venous pressure gradient in patients with portal hypertension.
Straumann A; Gyr K; Kiowski W; Bruendler H; Stalder GA
Hepatogastroenterology; 1986 Jun; 33(3):101-4. PubMed ID: 3744280
[TBL] [Abstract][Full Text] [Related]
5. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
[TBL] [Abstract][Full Text] [Related]
6. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
[TBL] [Abstract][Full Text] [Related]
7. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T
Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
Mastai R; Bosch J; Navasa M; Kravetz D; Bruix J; Viola C; Rodés J
J Hepatol; 1987 Feb; 4(1):71-9. PubMed ID: 3033061
[TBL] [Abstract][Full Text] [Related]
9. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
Møller S; Brinch K; Henriksen JH; Becker U
J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
[TBL] [Abstract][Full Text] [Related]
10. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
Iwao T; Toyonaga A; Ikegami M; Sugawara H; Sumino M; Takagi K; Oho K; Sakaki M; Ohkubo K; Inoue R
Am J Gastroenterol; 1992 Mar; 87(3):326-31. PubMed ID: 1539567
[TBL] [Abstract][Full Text] [Related]
11. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
Li S
Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):207-9. PubMed ID: 8275833
[TBL] [Abstract][Full Text] [Related]
12. Time profile of the haemodynamic effects of terlipressin in portal hypertension.
Escorsell A; Bandi JC; Moitinho E; Feu F; García-Pagan JC; Bosch J; Rodés J
J Hepatol; 1997 Mar; 26(3):621-7. PubMed ID: 9075670
[TBL] [Abstract][Full Text] [Related]
13. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
Navasa M; Chesta J; Bosch J; Rodés J
Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
[TBL] [Abstract][Full Text] [Related]
14. Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis.
Eriksson LS; Law DH; Sato Y; Wahren J
Clin Physiol; 1984 Feb; 4(1):5-11. PubMed ID: 6141861
[TBL] [Abstract][Full Text] [Related]
15. Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension.
Albillos A; Rossi I; Iborra J; Lledó JL; Calleja JL; Barrios C; García P; Escartín P
J Hepatol; 1994 Jul; 21(1):88-94. PubMed ID: 7963427
[TBL] [Abstract][Full Text] [Related]
16. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone.
Iwao T; Toyonaga A; Ikegami M; Oho K; Sumino M; Sakaki M; Shigemori H; Nakayama M; Sasaki E; Tanikawa K
J Hepatol; 1993 Nov; 19(3):345-52. PubMed ID: 8151095
[TBL] [Abstract][Full Text] [Related]
17. Lack of effects of nifedipine on hepatic hemodynamics in patients with HBsAg-positive cirrhosis.
Lay CS; Tsai YT; Kong CW; Lee FY; Lee SD; Lo KJ; Chiang BN; Chen KY
Liver; 1987 Aug; 7(4):223-7. PubMed ID: 3683094
[TBL] [Abstract][Full Text] [Related]
18. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis.
Braillon A; Cales P; Valla D; Gaudy D; Geoffroy P; Lebrec D
Gut; 1986 Oct; 27(10):1204-9. PubMed ID: 3781335
[TBL] [Abstract][Full Text] [Related]
19. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function.
Ikegami M; Toyonaga A; Tanikawa K
Am J Gastroenterol; 1992 Sep; 87(9):1160-4. PubMed ID: 1519573
[TBL] [Abstract][Full Text] [Related]
20. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension.
Navasa M; Bosch J; Reichen J; Bru C; Mastai R; Zysset T; Silva G; Chesta J; Rodés J
Hepatology; 1988; 8(4):850-4. PubMed ID: 3391511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]